+46.1%
GSK vs POET
+120.8%
-74.7%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | POET | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +4.6% | -4.6% | 0.0% |
| 7D | -3.5% | +0.4% | -3.9% | -3.5% |
| 30D | -3.4% | -10.4% | +6.9% | -3.4% |
| 3M | -8.1% | -29.3% | +21.2% | -8.1% |
| 6M | -11.1% | +6.9% | -18.0% | -11.8% |
| YTD | +0.7% | +25.6% | -24.9% | -0.2% |
| 1Y | +20.1% | +49.2% | -29.0% | +18.3% |
| 3Y | +46.1% | +128.4% | -82.3% | +46.3% |
| All | +46.1% | +120.8% | -74.7% | +46.3% |
Cumulative growth
Daily Returns
Daily percentage return beside POET.
Daily Out/Under-Performance
Portfolio return minus POET return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × POET return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded POET wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling